Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.
2.

Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.

Mintzes B, Morgan S, Wright JM.

PLoS One. 2009 May 27;4(5):e5699. doi: 10.1371/journal.pone.0005699.

3.

Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions.

Dorn SD, Farley JF, Hansen RA, Shah ND, Sandler RS.

Gastroenterology. 2009 Aug;137(2):518-24, 524.e1-2. doi: 10.1053/j.gastro.2009.05.005. Epub 2009 May 13.

4.

How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.

Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, Evans RG, Pan R, Marion SA.

CMAJ. 2003 Sep 2;169(5):405-12.

5.

A decade of direct-to-consumer advertising of prescription drugs.

Donohue JM, Cevasco M, Rosenthal MB.

N Engl J Med. 2007 Aug 16;357(7):673-81.

6.

Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid.

Law MR, Soumerai SB, Adams AS, Majumdar SR.

Arch Intern Med. 2009 Nov 23;169(21):1969-74. doi: 10.1001/archinternmed.2009.320.

PMID:
19933958
7.

Promotion of prescription drugs to consumers.

Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM.

N Engl J Med. 2002 Feb 14;346(7):498-505.

8.

The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?

Morgan S, Mintzes B, Barer M.

J Health Serv Res Policy. 2003 Oct;8(4):237-44.

PMID:
14596759
9.

The impact of pharmaceutical direct advertising: opportunities and obstructions.

Pinto MB, Pinto JK, Barber JC.

Health Mark Q. 1998;15(4):89-101.

PMID:
10185455
10.

Should Canada allow direct-to-consumer advertising of prescription drugs?: yes.

Wong-Rieger D.

Can Fam Physician. 2009 Feb;55(2):130, 132, 134 passim. English, French. No abstract available.

11.

Relationship between direct-to-consumer advertising and physician diagnosing and prescribing.

Zachry WM 3rd, Shepherd MD, Hinich MJ, Wilson JP, Brown CM, Lawson KA.

Am J Health Syst Pharm. 2002 Jan 1;59(1):42-9.

PMID:
11813466
12.
13.

Benefits and harms of direct to consumer advertising: a systematic review.

Gilbody S, Wilson P, Watt I.

Qual Saf Health Care. 2005 Aug;14(4):246-50. Review.

14.

Should Canada allow direct-to-consumer advertising of prescription drugs?: no.

Mintzes B.

Can Fam Physician. 2009 Feb;55(2):131, 133, 135 passim. English, French. No abstract available.

15.

The price of seduction: direct-to-consumer advertising of prescription drugs in the US.

Marks JH.

N C Med J. 2003 Nov-Dec;64(6):292-5. No abstract available.

PMID:
14983622
16.

Direct-to-consumer marketing: how has it fared?

Fintor L.

J Natl Cancer Inst. 2002 Mar 6;94(5):329-31. No abstract available.

PMID:
11880470
17.

Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?

Rosenthal M.

J Health Serv Res Policy. 2004 Jan;9(1):39-42; discussion 41-2. No abstract available.

PMID:
15006239
18.

The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.

Hansen RA, Schommer JC, Cline RR, Hadsall RS, Schondelmeyer SW, Nyman JA.

Res Social Adm Pharm. 2005 Jun;1(2):139-57.

PMID:
17138472
19.
20.

Direct-to-consumer prescription drug advertising: trends, impact, and implications.

Wilkes MS, Bell RA, Kravitz RL.

Health Aff (Millwood). 2000 Mar-Apr;19(2):110-28. Review.

PMID:
10718026

Supplemental Content

Support Center